MODULATION OF TYPE-IV COLLAGENASE ACTIVITY AND INVASIVE BEHAVIOR OF METASTATIC HUMAN-MELANOMA (A2058) CELLS-INVITRO BY MONOCLONAL-ANTIBODIES TO TYPE-IV COLLAGENASE
MODULATION OF TYPE-IV COLLAGENASE ACTIVITY AND INVASIVE BEHAVIOR OF METASTATIC HUMAN-MELANOMA (A2058) CELLS-INVITRO BY MONOCLONAL-ANTIBODIES TO TYPE-IV COLLAGENASE
复制标题
DOI:
10.1002/ijc.2910460224
复制
发表时间:
1990-08-15
影响因子:
6.4
通讯作者:
TRYGGVASON, K
中科院分区:
文献类型:
--
作者:
HOYHTYA, M;HUJANEN, E;TRYGGVASON, K
Monoclonal antibodies (MAbs) against human type-IV collagenase were developed and used for studies on enzyme activity and tumor-cell invasion in vitro. Fifteen MAb clones were generated against the enzyme purified from serum-free culture medium of human melanoma cells (A2058). Five clones affecting the activity of type-IV collagenase were selected for further characterization. All the selected clones could be used for a single-step purification of type-IV collagenase using IgG-Sepharose affinity columns. One of the antibodies activated the enzyme when 3H-proline-labelled type-IV collagen was used as substrate. The activation was dependent on the enzyme antibody ratio. Four clones more than 30% inhibition of the activity, maximal inhibition being 50%. Interestingly, the same antibody which activated the enzyme also increase the invasion of A2058 cells through a reconstituted basement membrane in an in vitro invasion assay. The 4 inhibitory antibodies decreased the penetration of A2058 cells through the reconstituted basement membrane. The results strongly support previous findings about the importance of type-IV collagenase in tumor-cell invasion.